Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Stanford University · with National Institute of Allergy and Infectious Diseases (NIAID) · NCT04579588
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 9–64 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 230
- US sites recruiting
- 1
- Study start
- October 29, 2020
- Record last updated
- March 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Being studied: Flu shot
Conditions: Corona Virus Infection; Flu Vaccine; Immunity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 9 through 64 years
- Diagnosed with COVID-19 at least 2 months prior enrollment
- Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms
- Patients without COVID-19 diagnosis for controls
Exclusion Criteria
- Received the influenza vaccine less than 4 months ago
- Pregnant or lactating
- Patients with special risks attendant to venipuncture
- Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment
- Contraindication to the flu vaccine
- Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement
Recruiting US locations
Stanford University
Palo Alto, CA 94304
Site contact: SNP Center Inquiry · (650) 521-7237 · snpcenterallergy_inquiry@stanford.edu
Study contacts (from the official record)
- SNP Center Inquiry · (650) 521-7237 · snpcenterallergy_inquiry@stanford.edu
Similar studies in California
All vaccine studies in California →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- La Mesa, CA + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Huntington Beach, CA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Madera, CA + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Sanofi
- Location
- Rolling Hills Estates, CA + 15 other US sites
- Eligibility basics
- Ages 18+